These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31915204)

  • 1. Plasma
    Wittenbecher C; Štambuk T; Kuxhaus O; Rudman N; Vučković F; Štambuk J; Schiborn C; Rahelić D; Dietrich S; Gornik O; Perola M; Boeing H; Schulze MB; Lauc G
    Diabetes Care; 2020 Mar; 43(3):661-668. PubMed ID: 31915204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease.
    Birukov A; Plavša B; Eichelmann F; Kuxhaus O; Hoshi RA; Rudman N; Štambuk T; Trbojević-Akmačić I; Schiborn C; Morze J; Mihelčić M; Cindrić A; Liu Y; Demler O; Perola M; Mora S; Schulze MB; Lauc G; Wittenbecher C
    Diabetes Care; 2022 Nov; 45(11):2729-2736. PubMed ID: 36174116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty Acid-Binding Protein 4 and Risk of Type 2 Diabetes, Myocardial Infarction, and Stroke: A Prospective Cohort Study.
    Aleksandrova K; Drogan D; Weikert C; Schulze MB; Fritsche A; Boeing H; Pischon T
    J Clin Endocrinol Metab; 2019 Dec; 104(12):5991-6002. PubMed ID: 31211381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinol and Retinol Binding Protein 4 Levels and Cardiometabolic Disease Risk.
    Schiborn C; Weber D; Grune T; Biemann R; Jäger S; Neu N; Müller von Blumencron M; Fritsche A; Weikert C; Schulze MB; Wittenbecher C
    Circ Res; 2022 Sep; 131(7):637-649. PubMed ID: 36017698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
    Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
    BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.
    Colombo M; Looker HC; Farran B; Agakov F; Brosnan MJ; Welsh P; Sattar N; Livingstone S; Durrington PN; Betteridge DJ; McKeigue PM; Colhoun HM
    Atherosclerosis; 2018 Jul; 274():182-190. PubMed ID: 29793175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel protein glycan biomarker and future cardiovascular disease events.
    Akinkuolie AO; Buring JE; Ridker PM; Mora S
    J Am Heart Assoc; 2014 Sep; 3(5):e001221. PubMed ID: 25249300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts.
    Floegel A; Kühn T; Sookthai D; Johnson T; Prehn C; Rolle-Kampczyk U; Otto W; Weikert C; Illig T; von Bergen M; Adamski J; Boeing H; Kaaks R; Pischon T
    Eur J Epidemiol; 2018 Jan; 33(1):55-66. PubMed ID: 29181692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A newly developed and externally validated non-clinical score accurately predicts 10-year cardiovascular disease risk in the general adult population.
    Schiborn C; Kühn T; Mühlenbruch K; Kuxhaus O; Weikert C; Fritsche A; Kaaks R; Schulze MB
    Sci Rep; 2021 Oct; 11(1):19609. PubMed ID: 34608230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease and Mortality in Individuals With Type 2 Diabetes.
    Hanssen NMJ; Westerink J; Scheijen JLJM; van der Graaf Y; Stehouwer CDA; Schalkwijk CG;
    Diabetes Care; 2018 Aug; 41(8):1689-1695. PubMed ID: 29784769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinally changed diet quality scores and their association with type 2 diabetes mellitus and cardiovascular diseases in the EPIC-Potsdam study.
    Jannasch F; Nickel DV; Kuxhaus O; Schulze MB
    Sci Rep; 2024 Jun; 14(1):13907. PubMed ID: 38886373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone markers and cardiovascular risk in type 2 diabetes patients.
    Zwakenberg SR; van der Schouw YT; Schalkwijk CG; Spijkerman AMW; Beulens JWJ
    Cardiovasc Diabetol; 2018 Mar; 17(1):45. PubMed ID: 29571288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of familial history of diabetes or myocardial infarction and stroke with risk of cardiovascular diseases in four German cohorts.
    Mühlenbruch K; Menzel J; Dörr M; Ittermann T; Meisinger C; Peters A; Kluttig A; Medenwald D; Bergmann M; Boeing H; Schulze MB; Weikert C
    Sci Rep; 2020 Sep; 10(1):15373. PubMed ID: 32958955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Glycosylation Profiles of Immunoglobulin G and Future Cardiovascular Events.
    Hoshi RA; Plavša B; Liu Y; Trbojević-Akmačić I; Glynn RJ; Ridker PM; Cummings RD; Gudelj I; Lauc G; Demler OV; Mora S
    Circ Res; 2024 Mar; 134(5):e3-e14. PubMed ID: 38348651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are diabetes risk scores useful for the prediction of cardiovascular diseases? Assessment of seven diabetes risk scores in the KORA S4/F4 cohort study.
    Kowall B; Rathmann W; Bongaerts B; Thorand B; Belcredi P; Heier M; Huth C; Rückert IM; Stöckl D; Peters A; Meisinger C
    J Diabetes Complications; 2013; 27(4):340-5. PubMed ID: 23659777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies.
    Razquin C; Ruiz-Canela M; Clish CB; Li J; Toledo E; Dennis C; Liang L; Salas-Huetos A; Pierce KA; Guasch-Ferré M; Corella D; Ros E; Estruch R; Gómez-Gracia E; Fitó M; Lapetra J; Romaguera D; Alonso-Gómez A; Serra-Majem L; Salas-Salvadó J; Hu FB; Martínez-González MA
    Cardiovasc Diabetol; 2019 Nov; 18(1):151. PubMed ID: 31722714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM model.
    Helmink MAG; Peters SAE; Westerink J; Harris K; Tillmann T; Woodward M; van Sloten TT; van der Meer MG; Teraa M; Dorresteijn JAN; Ruigrok YM; Visseren FLJ; Hageman SHJ;
    Eur J Prev Cardiol; 2024 Oct; 31(14):1671-1678. PubMed ID: 38584392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.
    Durand M; Chartrand-Lefebvre C; Baril JG; Trottier S; Trottier B; Harris M; Walmsley S; Conway B; Wong A; Routy JP; Kovacs C; MacPherson PA; Monteith KM; Mansour S; Thanassoulis G; Abrahamowicz M; Zhu Z; Tsoukas C; Ancuta P; Bernard N; Tremblay CL;
    BMC Infect Dis; 2017 Sep; 17(1):611. PubMed ID: 28893184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family history of myocardial infarction, stroke and diabetes and cardiometabolic markers in children.
    Berentzen NE; Wijga AH; van Rossem L; Koppelman GH; van Nieuwenhuizen B; Gehring U; Spijkerman AM; Smit HA
    Diabetologia; 2016 Aug; 59(8):1666-74. PubMed ID: 27239670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaussian graphical models identified food intake networks and risk of type 2 diabetes, CVD, and cancer in the EPIC-Potsdam study.
    Iqbal K; Schwingshackl L; Floegel A; Schwedhelm C; Stelmach-Mardas M; Wittenbecher C; Galbete C; Knüppel S; Schulze MB; Boeing H
    Eur J Nutr; 2019 Jun; 58(4):1673-1686. PubMed ID: 29761319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.